BioHealth News Archive
JPM: Roche, Illumina unveil 15-year cancer diagnostic tie-up | FierceBiotech
SAN FRANCISCO—Roche has inked a 15-year partnership with Illumina in oncology, which will include collaborating on new companion diagnostic indications for the DNA sequencing…
Read MorePrecigen Receives FDA Orphan Drug Designation for PRGN-3006 UltraCAR-T™ in Patients With Acute Myeloid Leukemia (AML) – BioHealth Capital Region
GERMANTOWN, Md., Jan. 6, 2020 /PRNewswire/ — Precigen, Inc., a biopharmaceutical company specializing in the development of innovative gene and cellular therapies to improve the lives…
Read MoreNIST wants to update iEdison tech-transfer portal to get it out of the ’90s
The National Institute of Standards and Technology is seeking public feedback on its plan to revamp the Interagency Edison (iEdison) System, an online portal where…
Read MoreMaryland Department of Commerce names Allyson Redpath entrepreneurship director – Bizwomen
The Maryland Department of Commerce has created a new role focused on the state's startup ecosystem and tapped a former investment banker and angel…
Read MoreBiobuzz Directory – Local Biotech, Hememics Biotechnologies Inc., has secured a $2.5 million investment
Rockville, Maryland-based Hememics Biotechnologies Inc. has secured a $2.5 million investment from AMVI Partners, an international investment firm with offices in McLean, Virginia. The startup is working…
Read MoreIBT Vaccines Receives $3.9 mil. to Advance Development of IBT-V02, the First Multivalent Toxoid Vaccine for MRSA | Integrated BioTherapeutics
IBT Vaccines, a wholly owned subsidiary of Integrated Biotherapeutics Inc., announces it has received $3.9 million to advance the development of the IBT-V02 vaccine for…
Read MoreThink universities are making lots of money from inventions? Think again. – The Washington Post
When Daria Mochly-Rosen discovered a compound in her lab that promised to lessen the effects of heart attacks, she set out to convince pharmaceutical…
Read MoreNotes and Takeaways from JPM 2020
The big deal about the just-completed J.P. Morgan (JPM) 38th Healthcare Conference had little to do with big M&A deals, because there weren’t any.…
Read MoreHow Much Should I Pay The Directors On My Board In 2020?
When was the last time you analyzed how much you should pay your board members? How do you know if you are paying too…
Read MoreAMPEL BioSolutions Announces Gene-Based Lupus Diagnostic At Biotech Showcase In San Francisco
SAN FRANCISCO, Jan. 17, 2020 /PRNewswire/ -- AMPEL BioSolutions' Co-Founder and COO/CSO Dr. Amrie Grammer today at the Biotech Showcase at JP Morgan Healthcare announces…
Read MoreThe CEO Chronicles – Lessons Learned From A Serial CEO | LinkedIn
Why me? I have spent the last 20 years as a serial CEO of multiple healthcare startups, as well as spending the last 3…
Read MoreSeeking Partner to Help Save Womens’ Lives Through Easy-to-Use and Analyze Cervical Cancer Screening Test/MarkPap® System
BioSciCon, Inc., a woman-owned small business based in Rockville, Maryland focused on providing a low-cost and accessible diagnostic system for the detection of cervical…
Read MoreFARXIGA granted FDA Priority Review for patients with heart failure with reduced ejection fraction
AstraZeneca today announced the US Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) and granted Priority Review for FARXIGA®…
Read MoreAnnouncing IndoUSrare | LinkedIn
Hi, I am Harsha Rajasimha, Founder and Chairman of IndoUSrare, an independent non-profit organization focused on helping patients with rare diseases of Indian origin…
Read MoreNCC PDI showcase event applications opens | Children’s National Hospital
WASHINGTON – The National Capital Consortium for Pediatric Device Innovation (NCC-PDI), in collaboration with MedTech Innovator, is now accepting applications for its showcase pitch…
Read More